References
- Steen VD, Medsger TA. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am. 1990; 16(1):1-10.
- Medsger TA Jr. Epidemiology of systemic sclerosis. Clin Dermatol. 1994; 12(2):207-216.
- Scussel-Lonzetti L, Joyal F, Raynauld JP, et al. Predicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore). 2002; 81(2):154-67.
- Shand L, Lunt M, Nihtyanova S, et al. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model. Arthritis Rheum. 2007; 56(7):2422-2431.
- Burchfield C, Vorrasi J. Maxillofacial Implications of Scleroderma and Systemic Sclerosis: A Case Report and Literature Review. J Oral Maxillofac Surg. 2019;77(6):1203-1208.
- Sozeri B, Gulez N, Aksu G, et al. Pesticide-induced scleroderma and early intensive immunosuppressive treatment. Arch Environ Occup Health. 2012; 67(1):43-47.
- Pollard KM, Pearson DL, Hultman P, et al. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ Health Perspect. 1999; 107(Suppl 5):729–735.
- Wynn TA. Fibrotic disease and the T (H) 1 / T (H) 2 paradigm. Nat Rev Immunol. 2004; 4(8):583–594.
- Granel B, Chevillard C, Allanore Y, et al. Evaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics. 2006;58(8):693–699.
- Matsushita T, Hasegawa M, Hamaguchi Y, et al. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol. 2006; 33(2):275–284.
- Mavalia C, Scaletti C, Romagnani P, et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol. 1997; 151(6):1751–1758.
- Hoffmann SC, Stanley EM, Darrin Cox E, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimu-lated peripheral blood lymphocytes. Transplantation. 2001;72(8):1444–1450.
- Suarez A, Castro P, Alonso R, et al. Inter-individual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation. 2003;75(5):711–717.
- Xu D, Mu R, Wei X. The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis. Front Immunol. 2019;10:2025.
- Hutyrova B, Lukac J, Bosak V, et al. Interleukin 1_ single nucleotide polymorphism associated with systemic sclerosis. J Rheumatol. 2004;31(1):81–84.
- Beretta L, Bertolotti F, Cappiello F, et al. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. Hum Immunol. 2007a; 68(7):603–609.
- Mattuzzi S, Barbi S, Carletto A, et al. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol. 2007; 34(5):997–1004.
- Crilly A, Hamilton J, Clark CJ, et al. Analysis of the 5’ flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxford). 2003;42(11):1295–1298.
- Beretta L, Cappiello F, Barili M, et al. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis. Tissue Antigens. 2007b; 69(4):305–312.
- Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum. 1980;23:581–90.
- Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Ann Rev Pathol. 2011; 6:509-537.
- Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med. 1998; 30(5):469-473.
- Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123(6):1793-1803.
- Iacoviello L, Di Castelnuovo A, Gattone M, et al. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2005;25(1):222-227.
- Wen AQ, Gu W, Wang J, et al. Clinical relevance of IL-1β promoter polymorphisms (-1470,-511, and-31) in patients with major trauma. Shock. 2010; 33(6):576–582.
- Yin WT, Pan YP, Lin L. Association between IL-1α rs17561 and IL-1β rs1143634 polymorphisms and periodontitis: a meta-analysis. Genet Mol Res. 2016;15(1).
- Lavu V, Venkatesan V, Venugopal P, et al. Clinical Relevance of Cytokines Gene Polymorphisms and Protein Levels in Gingival Cervical Fluid from Chronic Periodontitis Patients. Iran J Immunol. 2017;14(1):51-58.
- Jagadish R, Mehta DS, Jagadish P. Oral and periodontal manifestations associated with systemic sclerosis: a case series and review. J Indian Soc Periodontol. 2012;16(2):271–274.
- Grewal IS. Overview of TNF superfamily: a chest full of potential therapeutic targets. Adv Exp Med Biol. 2009;647:1-7.
- Kantor TV, Frieberg D, Medsger TA Jr, et al. Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol. 1992;65(3):278-285.
- Young V, Ho M, Vosper H, et al. Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leukocytes from patients with systemic sclerosis. Rheumatology (Oxford). 2002; 41(8):869-875.
- Bolster MB, Ludwicka A, Sutherland SE, et al. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997; 40(4):743-751.
- Mathai SK, Gulati M, Peng X, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest. 2010; 90(6):812-823.
- Azab E, Elfasakhany FM. Effect of tumor necrosis factor alpha (TNF-α)-308 and-1031 gene polymorphisms on periodontitis among Saudi subjects. Saudi Dent J. 2022;34(3):226-231.
- Huizinga TW, Westendorp RG, Bollen EL, et al. TNF-alpha promoter polymorphisms, production, and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997; 72(2):149–153.
- Tolusso B, Fabris M, Caporali R, et al.-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis. Immunol Lett. 2005;96(1):103–108.
- Perrey C, Pravica V, Sinnott PJ, et al. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumor necrosis factor-α genes: a technical report. Transpl Immunol. 1998; 6(3):193–197.
- Saremi L, Shafizadeh M, Ghaffari ME, et al. Evaluation of interleukin 10, interleukin 1-beta, and tumor necrosis factor-alpha gene polymorphisms in patients with periodontitis and healthy controls. Egypt J Med Hum Genet. 2022;23:157.
- Zhou Y, Gsicombe R, Huang D, et al. Novel genetic association of Wegener’s granulomatosis with the interleukin-10 gene. J Rheumatol. 2002; 29(2):317–320.
- Crilly A, Hamilton J, Clark CJ, et al. Analysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis. 2002; 61(8):678–681.
- Sugiura Y, Banno S, Matsumoto Y, et al. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis. J Rheumatol. 2003; 30(7):1520–1523.
- Peoples C, Medsger TA Jr, Lucas M, et al. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord. 2016;1(2):177-240.